Strategic Investment Solutions’s ARK Genomic Revolution ETF ARKG Stock Holding History

Strategic Investment Solutions’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11K	Hold	74	–	–	﹤0.01%	559
2026 Q1	$1.96K	Hold	74	–	–	﹤0.01%	559
2025 Q4	$2.14K	Hold	74	–	–	﹤0.01%	534
2025 Q3	$2.06K	Hold	74	–	–	﹤0.01%	508
2025 Q2	$1.8K	Hold	74	–	–	﹤0.01%	506
2025 Q1	$1.54K	Hold	74	–	–	﹤0.01%	528
2024 Q4	$1.74K	Hold	74	–	–	﹤0.01%	535
2024 Q3	$1.89K	Sell	74 -5	-6%	-$127	﹤0.01%	501
2024 Q2	$5.02K	Buy	+79	New	+$1.99K	﹤0.01%	424
2023 Q4	$2.43K	Sell	74 -4,588	-98%	-$125K	﹤0.01%	945
2023 Q3	$152K	Buy	4,662 +4,588	+6,200%	+$150K	﹤0.01%	520
2023 Q2	$2.41K	Hold	74	–	–	﹤0.01%	741
2023 Q1	$2.23K	Buy	+74	New	+$2.29K	﹤0.01%	866

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Strategic Investment Solutions's ARKG Position: Q2 2026 in Review

Strategic Investment Solutions held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 74 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Strategic Investment Solutions first reported a position in ARKG in Q1 2023 and has held it in 13 quarters since. The position peaked at $152K in Q3 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Strategic Investment Solutions held 74 shares of ARK Genomic Revolution ETF worth $3.11K as of Q2 2026.
Strategic Investment Solutions left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q2 2026, its #559 holding.
Strategic Investment Solutions first reported a position in ARK Genomic Revolution ETF in Q1 2023 and has held it in 13 quarters since.
Strategic Investment Solutions's ARK Genomic Revolution ETF position peaked at $152K in Q3 2023.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.